Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
SHEZF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $5 | $5 | $5 | $5 |
| - Cash | $2 | $2 | $2 | $2 |
| + Debt | $2 | $3 | $3 | $3 |
| Enterprise Value | $5 | $6 | $6 | $6 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 2.1% | 15.1% | -1.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 34.9% | 27.3% | 33.4% | 29.5% |
| EBITDA | $0 | $0 | -$0 | $0 |
| % Margin | 22.7% | 14.4% | -10.8% | 14.7% |
| Net Income | $0 | $0 | -$0 | $0 |
| % Margin | 18.6% | 11.2% | -11% | 9.5% |
| EPS Diluted | 0.18 | 0.11 | -0.091 | 0.079 |
| % Growth | 63.6% | 221% | -214.5% | – |
| Operating Cash Flow | $1 | $1 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $1 | $0 | $0 |